The Clinical and Educational Core (Core B) of this Udall Center grant application will have two primary functions: 1) To recruit patients with Parkinson's disease (PD) and normal control subjects for the Udall Center's projects;and 2) To conduct educational and community outreach programs on the subjects of PD, Parkinson's disease with dementia (PDD) and dementia with Lewy Bodies (DLB). The Clinical and Education Core will draw research participants from clinics that provide care to over 2,500 patients with PD. The primary source of subjects will be the University of Pennsylvania Parkinson's Disease and Movement Disorders Center (PD&MDC). Other sources of subjects include the Philadelphia Veterans Hospital Parkinson's Disease Research, Education and Clinical Center (PADRECC) and the American Parkinson's Disease Association (APDA) Center at Crozier-Chester Medical Center and other clinics in the University of Pennsylvania Health System (UPHS). Patients and controls will consent to detailed clinical and neuropsychological evaluations and will be asked to donate blood, urine and cerebro- spinal fluid, as well as brain tissue upon their death, to advance the goals of the Udall Center, including the identification of potential biomarkers (e.g. peripheral biochemical analytes and genetic markers in blood and urine as well as CSF tau and isoprostanes) of PD-related neurodegeneration. The educational component of Core B will be implemented through outreach to the community through programs modeled on successful examples conducted by the PD&MDC and new outreach to the minority and underserved populations of the city of Philadelphia. Collaboration with organizations currently connected to the PD&MDC, particularly the local Parkinson's Disease Council, the Dan Aaron Parkinson Disease Foundation, and a large network of patient and family PD support groups already engaged in outreach, will support this effort. Physician education will take two forms: 1) lectures and symposia offered to practicing physicians and other healthcare providers on the diagnosis and management of parkinsonism and cognitive disorders;and 2) training of a series of at least 3 movement disorders research fellows who will participate in the Udall Center's core activities .and projects. An additional function of Core B will be to work with the Data Management/Biostatistics Core D to establish a comprehensive and standardized clinical database. This database will be the repository for all data on patients participating in the Udall center in a format designed to facilitate sharing of data with similar clinical databases created by other Udall centers under the auspices of the recently funded PD Data Organizing Center (PD-DOC) as part of the NINDS Udall Center Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS053488-05
Application #
8298526
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
2012-08-31
Budget Start
2011-06-01
Budget End
2013-05-31
Support Year
5
Fiscal Year
2011
Total Cost
$370,027
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Olm, Christopher A; McMillan, Corey T; Irwin, David J et al. (2018) Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers. Neuroimage Clin 19:497-506
Sandelius, Åsa; Portelius, Erik; Källén, Åsa et al. (2018) Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. Alzheimers Dement :
Henderson, Michael X; Peng, Chao; Trojanowski, John Q et al. (2018) LRRK2 activity does not dramatically alter ?-synuclein pathology in primary neurons. Acta Neuropathol Commun 6:45
Chahine, L M; Dos Santos, C; Fullard, M et al. (2018) Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Eur J Neurol :
Cousins, Katheryn A Q; Ash, Sharon; Grossman, Murray (2018) Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). Cortex 100:127-139
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Shi, Min; Tang, Lu; Toledo, Jon B et al. (2018) Cerebrospinal fluid ?-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimers Dement 14:1052-1062
Tropea, Thomas F; Xie, Sharon X; Rick, Jacqueline et al. (2018) APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease. Mov Disord 33:289-297
Portelius, Erik; Olsson, Bob; Höglund, Kina et al. (2018) Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol 136:363-376
Polinski, Nicole K; Volpicelli-Daley, Laura A; Sortwell, Caryl E et al. (2018) Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. J Parkinsons Dis 8:303-322

Showing the most recent 10 out of 339 publications